Middletown, DE -- (SBWIRE) -- 08/14/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: LVMH Moet Hennessy Louis Vuitton SA(ADR)(OTCMKTS:LVMUY), Anavex Life Sciences Corp(OTCMKTS:AVXL), AMARANTUS BIOSCIENCE HOLDINGS, INC.(OTCBB:AMBS), OncoSec Medical Inc(OTCMKTS:ONCS)
LVMH Moet Hennessy Louis Vuitton SA(ADR)(OTCMKTS:LVMUY) ended lower-0.11% and complete the day at $37.23. The total number of shares changed hands during the day was 94,230 . After opening at $37.25, the stock hit as high as $37.35. However, it traded between $29.00 and $38.47 over the last twelve months.
LVMH Moet Hennessy Louis Vuitton SA, (LVMH), is a France-based luxury goods company. It owns a portfolio of luxury brands and its business activities are divided into five segments: Wines and Spirits, Fashion and Leather Goods, Perfumes and Cosmetics, Watches and Jewelry, and Selective Retailing.
Has LVMUY Found The Bottom and Ready To Move Up? Find Out Here
Anavex Life Sciences Corp(OTCMKTS:AVXL) closed yesterday at $0.730, a +7.35% increase. Around 311,153 shares were traded, beating an-average trading volume of 110,977 shares. The company is now valued at around $22.08 million.
Anavex Life Sciences Corp. (Anavex) is a development-stage company. Anavex is a biopharmaceutical company engaged in the discovery and development of drug targets to treat diseases.
For How Long AVXL Gloss will Attract Investors? Find out via this report
AMARANTUS BIOSCIENCE HOLDINGS, INC.(OTCBB:AMBS) moved +1.33 percent higher at $0.038 and traded between $0.036 and $0.042 after opening the day at $0.0399.
Amarantus BioScience Holdings, Inc., a development-stage biotechnology company, focuses on the discovery and development of drug candidates and diagnostic blood tests to diagnose and treat human diseases in the United States. The company is developing the Mesencephalic-Astrocyte-derived Neurotrophic Factor, a therapeutic protein to treat Parkinson?s diseases, as well as for other apoptosis-related disorders, including ischemic heart disease.
For How Long AMBS Gloss will Attract Investors?Find out via this report
OncoSec Medical Inc(OTCMKTS:ONCS) shares rose, gaining +9.76 percent to close at $0.315. The stock is up around 43.18% this year and 65.79% for the last 12 months. Around 1.08 million shares changed hands yesterday, lower from an-average trading volume of 1.70 million shares.
OncoSec Medical Incorporated is an emerging drug-medical device company. The Company focused on designing, developing and commercializing medical approaches for the treatment of solid cancers. In March 2011, the Company acquired from Inovio Pharmaceuticals, Inc. (Inovio) certain assets related to the use of drug-medical device combination products for the treatment of different cancers.
Why Should Investors Buy ONCS After The Recent Gain?Just Go Here and Find Out
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)